Stock Events

Stock Events

Corvus Pharmaceuticals (C17.F) Q4 2024 Earnings

12NovConfirmed

Q3 2023

Q2 2024

Q3 2024

Q4 2024

-0.57

-0.4

-0.23

-0.06

Details

Expected EPS

-0.1036145

Actual EPS

-0.56517

Surprise EPS

-0.46

Surprise Percent

+445.45%

Description

Corvus Pharmaceuticals (C17.F) has reported earnings of -0.56517 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.